Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice
Hui‐Tsu Lin, Cheng-Cheung Chen, Der-Jiang Chiao, et al.
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 1885-1897
Open Access | Times Cited: 15

Showing 15 citing articles:

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
Biswajita Pradhan, Rabindra Nayak, Srimanta Patra, et al.
Carbohydrate Polymers (2022) Vol. 291, pp. 119551-119551
Open Access | Times Cited: 74
Fucoidan-based nanoparticles: Preparations and applications
Jayachandran Venkatesan, Sesha Subramanian Murugan, Gi Hun Seong
International Journal of Biological Macromolecules (2022) Vol. 217, pp. 652-667
Closed Access | Times Cited: 43
The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
Yuan Hu, Lili Liu, Shenghua Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 5, pp. 5175-5192
Open Access | Times Cited: 6
Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
Yani Li, Eileen McGowan, Size Chen, et al.
Marine Drugs (2023) Vol. 21, Iss. 2, pp. 128-128
Open Access | Times Cited: 14
Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review
Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 98-98
Open Access | Times Cited: 10
Antigenicity and immunogenicity of chikungunya virus-like particles from mosquito cells
Shan-Ko Tsai, Yu‐Lin Hsu, Der-Jiang Chiao, et al.
Applied Microbiology and Biotechnology (2022) Vol. 107, Iss. 1, pp. 219-232
Open Access | Times Cited: 9
Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2
Khue G. Nguyen, Siena M. Mantooth, Maura R. Vrabel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice
Yang Song, Hongqiao Hu, Kang Xiao, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 4
Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design
Xueyin Mei, Pan Gu, Chuanlai Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
Volodymyr V. Oberemok, Oksana A. Andreeva, Edie E. Alieva
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1553-1553
Open Access | Times Cited: 3
Scavenger receptor A in immunity and autoimmune diseases: Compelling evidence for targeted therapy
Yang Xie, Jia Yuan, Zhanguo Li, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 461-477
Closed Access | Times Cited: 5
Enhancing antibody levels and T cell activity of quadrivalent influenza vaccine by combining it with CpG HP021
Jia Ji, Lei Chen, Zhigang Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus
Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nasal Administration of M2e/CpG-ODN Encapsulated in N-Trimethyl Chitosan (TMC) Significantly Increases Specific Immune Responses in a Mouse Model.
Morteza Taghizadeh, Mehran Dabaghian
PubMed (2022) Vol. 77, Iss. 6, pp. 2259-2268
Closed Access | Times Cited: 2
Page 1

Scroll to top